Delivery Order SPE2DB22D1106-SPE2DB25FDTF5

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of 4,565,431,520 units of Fluticasone Prop HFA 220 MCG 12 GM. The contract is a firm fixed price agreement with a ceiling value of $1,121.75 and an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment facilities and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 44 MCG 10.6GM. The contract has a ceiling value of $1,130.94 and a period of performance through April 26, 2024. It is a firm fixed-price contract, with no set-aside designation, suggesting open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the supply of 4564313063 - Fluticasone Prop HFA 110 MCG 12GM. The contract has a firm fixed-price of $5,513.11 and a completion date of April 18, 2024. Amerisourcebergen, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of fluticasone propionate HFA 110 mcg 12 gram inhalers. The $3,227.09 firm fixed price contract has an ultimate completion date of July 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,415,474 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The contract has a firm fixed price of $1,542.47 and a period of performance ending on April 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,550,884 units of Fluticasone Prop HFA 220 MCG 12GM, a prescription medication. The contract has a firm fixed price of $2,484.87 and an ultimate completion date of August 23, 2024. This contract is not a set-aside. AmerisourceBergen Drug Corp has been awarded multiple contracts by the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,977.92, is for the delivery of fluticasone propionate HFA 110 MCG 12GM inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564557532 - Fluticasone Prop HFA 44 MCG 10.6GM. The contract has a ceiling value of $1,885.71 and runs through May 10, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 110 MCG 12GM medication. The contract has a ceiling value of $28,577.26 and runs through May 2024. It is a firm fixed-price contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,366.78 firm fixed-price contract is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a respiratory medication. The ultimate completion date is December 17, 2024. This contract award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTF5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 220 MCG 12GM. The contract has a firm-fixed price of $4,556.22 and a completion date of January 7, 2025. It is not designated as a set-aside contract.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 4/13/25, 12:50 AM